Dr. Wachman received her MD from the BU School of Medicine before pursuing her pediatric residency at Boston Medical Center (BMC) and Children’s Hospital Boston. She then completed her neonatology fellowship at the Floating Hospital for Children at Tufts Medical Center. She is currently an attending neonatologist at BMC and a leader in neonatal abstinence syndrome (NAS) quality improvement and research at BMC. Her research primarily focuses on examining genetic and epigenetic predictors of NAS outcomes. She is a site Co-Investigator of a NIDA clinical trial exploring optimal treatment options for NAS, as well as genetic variations and developmental outcomes in these high-risk infants. Her other primary research interests include the care of premature infants with NAS, and breastfeeding in the setting of maternal substance use disorders. Dr. Wachman has presented her research and numerous local and national conferences.